MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.

The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised prostate cancer.

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Americans may be receiving too much radiation from medical tests whose ...

Michigan State University has inaugurated the K500 Chip Testing Facility, which will help make microchips more reliable in high-radiation environments and increase U.S. capacity for radiation effects ...

Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to Cleveland Clinic research. The study, published in the Journal of ...

PITTSBURGH (KDKA) - There is radiation all around us. Radios, televisions, cell phones, and microwaves are all things that release radiation. These are considered to not be harmful, but there is ...